Clinical Trial WATCH | Ophthalmology

This summary is intended to provide a snapshot of the original research. It is in no way a substitute for the original research article, nor is it intended to be a complete reflection of the original research. 

Originally published in JAMA Ophthalmology, 3 July 2024

This retrospective matched cohort study examined the association between semaglutide and nonarteritic anterior ischemic optic neuropathy (NAION).

Propensity matching was used to evaluate the risk of NAION with semaglutide use in individuals with type 2 diabetes or in those who were overweight/obese, adjusting for covariates and contraindications.

Back to top 

Disclaimer
This article is compiled from various resources researched and compiled by the contributor. It is in no way presented as an original work.  Every effort has been made to attribute quotes and content correctly. Where possible,  all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 

Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.